Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer
贝伐珠单抗单药或联合TRC105治疗难治性转移性肾细胞癌患者
期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.30942
Dorff, Tanya B; Longmate, Jeff A; Pal, Sumanta K; Stadler, Walter M; Fishman, Mayer N; Vaishampayan, Ulka N; Rao, Amol; Pinksi, Jacek K; Hu, James S; Quinn, David I; Lara, Primo N Jr
